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Clinical relevance 
 
Scientific rationale for the study: the aim of this systematic review was to assess the 
efficacy of soft tissue augmentation procedures to gain keratinized mucosa around dental 
implants and to increase the soft tissue volume around implants and in partially 
edentulous areas 
Principal findings: An apically positioned flap/vestibuloplasty (APF/V) plus a graft 
material was considered a successful treatment concept resulting for gain of keratinized 
mucosa. The amount of keratinized mucosa could statistically significantly be increased 
combining an APF/V with autogenous tissue (FGG=free gingival 
graft)/SCTG=subepithelial connective tissue graft) when compared to control groups (no 
treatment, APF/V alone). The use of collagen matrices (CM) reduced surgery time and 
patient morbidity, but rendered less gain of keratinized mucosa compared to the use of 
autogenous tissue (SCTG). Autogenous grafts (SCTG/FGG) rendered a two- and three-
dimensional gain of soft tissue thickness at implant sites and partially edentulous sites. 
Practical implications: Larger evidence is available for APF/V plus autogenous tissue 
(FGG/SCTG) and supports these procedures for gain of keratinized mucosa. If surgery 
time and patient morbidity are considered, APF/V plus CM may be recommended as an 
alternative treatment modality, even though rendering less gain in keratinized mucosa 
and being less documented. For soft tissue volume increase, the use of autogenous 
grafts (SCTG/FGG) has to be considered as gold standard. No soft tissue substitute 
materials can be recommended for this procedure.  
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Abstract 
 
Aim: To review the dental literature in terms of efficacy of soft tissue augmentation 
procedures around dental implants and in partially edentulous sites.  
Methods: A Medline search was performed for human studies augmenting keratinized 
mucosa and soft tissue volume around implants and in partially edentulous areas. 
Relevant studies were identified and statistics reported for meta-analyses including 
weighted mean differences with 95% confidence intervals.  
Results: Nine (keratinized mucosa) and eleven (volume) studies met the inclusion 
criteria. An apically positioned flap/vestibuloplasty (APF/V) plus a graft material 
(FGG/SCTG/CM) (FGG=free gingival graft/SCTG=subepithelial connective tissue 
graft/CM=collagen matrix) resulted in an increase of up to 4mm of keratinized mucosa. 
Based on meta-analysis, statistically significantly better outcomes were obtained for 
APF/V plus FGG/SCTG compared to controls (APF/V alone; no treatment) (p<0.05). For 
surgery time and patient morbidity, statistically significantly better outcomes were 
reported for collagen matrices (CM) compared to SCTGs (p<0.05), even though 
rendering less keratinized tissue. SCTGs were the best-documented method for gain of 
soft tissue volume at implant sites and partially edentulous sites. Esthetically at 
immediate implant sites, better papilla fill and higher marginal mucosal levels were 
obtained using SCTGs compared to non-grafted sites. 
Conclusions: An APF/V plus FGG/SCTG was the best-documented and most successful 
method to increase the width of keratinized mucosa. APF/V plus CM demonstrated less 
gain in keratinized mucosa, but also less patient morbidity and surgery time compared to 
APF/V plus SCTG based on two randomized controlled clinical trials. Autogenous grafts 
(SCTG) rendered an increase in soft tissue thickness and better esthetics compared to 
non-grafted sites.  
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Introduction 
 
Plastic periodontal procedures to augment keratinized tissue and to increase soft 
tissue volume are well described (Cairo et al., 2008, Thoma et al., 2009). These 
procedures are indicated to establish functional and biological stability around teeth and 
implants, mainly in conjunction with reconstructive therapy. The question whether or not 
there is a need for keratinized tissue to maintain periodontal health around teeth and 
peri-implant health around dental implants has been controversially discussed in the 
literature citing a number of parameters to be considered: i) establishment and 
maintenance of biological health, ii) prevention of recession, iii) esthetics and, iv) 
cleansibility of the reconstruction (Hoelscher and Simons, 1994, Marquez, 2004, Mehta 
and Lim, 2010, Wennstrom and Derks, 2012). For dental implants, clinical evidence 
suggests that a lack of keratinized mucosa (KM) may not be crucial in maintaining the 
health of peri-implant soft tissues (Wennstrom et al., 1994), may not be associated with 
more bone loss (Chung et al., 2006) or that despite the presence of KM, peri-implantitis 
may occur (Roos-Jansaker et al., 2006). In contrast, more recent clinical studies 
concluded that a wider zone of KM may better preserve soft and hard tissue stability 
(Bouri et al., 2008), may be more favorable for the long-term maintenance of dental 
implants (Kim et al., 2009) and that a lack of KM may result in poorer oral hygiene and 
greater soft tissue recession (Schrott et al., 2009). This resulted in a clinical 
recommendation of 2mm for the width of keratinized mucosa (Adibrad et al., 2009, 
Bengazi et al., 1996), a dimension similar to the zone of keratinized gingiva 
recommended to be adequate around teeth (Lang and Loe, 1972). Treatment-wise, 
plastic procedures to augment keratinized tissue include an apically positioned flap or a 
vestibuloplasty procedure (Thoma et al., 2009, Palacci and Nowzari, 2008). This can be 
performed prior to implant placement, simultaneously with second stage surgery or post 
insertion of the final reconstruction. Moreover, in order to compensate for hard and soft 
tissue deficits in localized defects, soft tissue volume augmentation is mainly indicated 
for esthetic reasons and to facilitate oral hygiene in pontic areas (Seibert, 1983a, Pini-
Prato et al., 2004). In these sites, the classic procedures include the use of free gingival 
grafts (FGG), subepithelial connective grafts (SCTG) and various types of roll and pedicle 
flaps (Seibert, 1983b, Studer et al., 2000, Batista et al., 2001, Cho, 1998, Breault et al., 
2004). In conjunction with dental implants, plastic augmentative procedures were 
recommended to enhance the thickness of the soft tissues simultaneously with implant 
placement or during the healing phase of the implants (Speroni et al., 2010, Grunder, 
2000, Schneider et al., 2011). Clinical studies demonstrated various techniques to be 
successful, resulting in greater flexibility for the choice of the reconstruction material, 
better esthetic outcomes with respect to the color of the peri-implant tissues, 
maintenance or even improvement of the marginal mucosal height and higher papillae 
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scores (Jung et al., 2008, Speroni et al., 2010, Cornelini et al., 2008, Kan et al., 2009). 
From a functional point of view however, there is still a lack of scientific evidence 
whether or not thicker peri-implant soft tissues result in better long-term success and 
survival rates of dental implants. 
Since controversy still exists with respect to the efficacy of soft tissue 
augmentation and new materials were evaluated more recently, there is a strong need to 
critically assess the dental literature for optimized procedures and graft materials in 
terms of soft tissue augmentation. 
Therefore, the aim of the present systematic review was to assess dental 
literature focusing on the efficacy of soft tissue augmentation procedures to increase the 
width of the keratinized mucosa around dental implants and to increase the soft tissue 
volume around implants and in partially edentulous areas.  
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Materials and Methods 
Protocol development and eligibility criteria 
A detailed protocol was developed and followed according to the PRISMA (Preferred 
Reporting Items for Systematic Review and Meta-Analyses) statement (Liberati et al., 
2009, Moher et al., 2009).  
Focused question 
What is the efficacy of different soft tissue augmentation methods in terms of i) 
increasing the width of keratinized mucosa, and ii) gain in soft tissue volume around 
implants and in partially edentulous areas? 
Search strategy 
A Medline (PubMed) search was performed for human studies, including articles 
published from January 1, 1966 up to May 15, 2013 in the dental literature. The search 
was limited to the English and German language. The search was complemented by 
manual searches of the reference list of all selected full-text articles. Additionally, full 
text articles of reviews published in the same time period were obtained. An additional 
hand search was performed searching for relevant studies by screening these reviews.  
Search Terms 
The following search terms were selected: “acellular dermal matrix” OR “dermal 
matrix allograft” OR “alloderm” OR “keratinized gingiva” OR “keratinized tissue” OR “soft 
tissue graft” OR “subepithelial connective tissue graft” OR “connective tissue“ OR “free 
gingival graft” OR “human fibroblast-derived dermal substitute” OR “dermagraft” OR 
“apligraf” OR “collagen matrix” OR “extracellular membrane” OR “gingival autograft” OR 
“attached gingiva” OR “attached mucosa” OR “keratinized mucosa” OR “soft tissue 
augmentation” OR “soft tissue transplantation” OR “vestibuloplasty“ OR “ridge 
augmentation” OR “soft tissue correction” OR “apically positioned flap” AND “dental 
implants” OR “Jaw, Edentulous, Partially” OR “pontic” (all MeSH terms) 
The search was limited to language (english, german), „human trial“ (MeSH term, 
clinical studies), and “Dental Journals”. Additionally, the MeSH terms: “case reports”, 
“clinical trial”, “comparative study”, “controlled clinical trial”, “randomized controlled 
trial”, “meta-analysis”, “review” and “systematic reviews” were used.   
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Inclusion criteria 
The applied inclusion criteria were different for studies dealing with gain of 
keratinized mucosa or gain of soft tissue volume.  
Increase in width of keratinized mucosa 
Any case series, cohort study, controlled clinical trial and randomized controlled 
clinical trial with at least 5 patients was included. A follow-up period of at least 3 months 
was required for the primary outcome “gain in keratinized mucosa”. The reported 
treatment outcomes had to include either clinical and/or histological measures of the 
width of keratinized mucosa. The primary outcome of the studies had to be localized gain 
in width of keratinized mucosa.  
augmentation of soft tissue volume around dental implant and in partially edentulous 
areas 
For studies focusing on soft tissue volume gain, any prospective case series, 
cohort study, controlled clinical trial and randomized controlled clinical trial with at least 
5 patients was included. The minimal follow-up time was 3 months for the primary 
outcome “gain in soft tissue volume”. The reported treatment outcomes had to include 
either clinical and/or histological measures of the soft tissue volume. 
The minimal follow-up time (3 months) for the primary outcome variables chosen 
in this systematic review is based on a lack of a scientific data with long-term results and 
in line with a previously published systematic review (Thoma et al., 2009). 
Exclusion criteria 
Studies not meeting all inclusion criteria were excluded from the review. 
Publications dealing with the following topics were also excluded: in vitro studies, 
preclinical (animal) studies, studies dealing with the treatment of recession defects, 
studies augmenting keratinized tissue around teeth only, studies augmenting soft tissue 
in fully edentulous patients, studies where the effect of soft tissue augmentation surgery 
could not be extracted from the data (e.g. combination of guided bone regeneration and 
soft tissue augmentation). 
Selection of studies 
Titles derived from this broad search were independently screened by 2 authors 
(DT, BB) based on the inclusion criteria. Disagreements were resolved by discussion. 
Cohen’s Kappa-coefficient was used as a measure of agreement between the 2 readers. 
Following this, abstracts of all titles agreed on by both authors were obtained, and 
screened for meeting the inclusion criteria. If no abstract was available in the database, 
the abstract of the printed article was used. The selected articles were then obtained in 
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full text. If title and abstract did not provide sufficient information regarding the inclusion 
criteria, the full report was obtained as well. Again, disagreements were resolved by 
discussion. 
Finally, the selection based on inclusion/exclusion criteria was made for the full 
text articles. For this purpose Material and Methods, and Results of these studies were 
screened. This step was again carried out independently by 2 readers. Disagreements 
were resolved by discussion.  
Data extraction 
Two reviewers independently extracted the data using data extraction tables. Any 
disagreements were resolved by discussion aiming for consensus.  
Quality assessment 
A quality assessment of the included randomized controlled clinical trials and controlled 
clinical studies was performed independently by two reviewers (BB, DTH) according to 
the Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated 
March 2011) (Higgins and Green, 2011). Three main quality criteria were assessed: 
allocation concealment, blinding treatment outcomes to outcome examiners and 
completeness of follow-up. The studies were then rated to have a low risk of bias (all 3 
criteria met) or a high risk of bias (one or more criteria not met). 
Statistical Analysis 
A test of heterogeneity was calculated to determine whether fixed or random effects 
models should be used for pooling of studies. Studies were pooled with inverse-variance 
weighting, and between study heterogeneity was estimated with the DerSimonian-Laird 
estimator. Meta-analyses were performed to compare treatment vs. no treatment, 
treatment a vs. treatment b and treatment a vs. treatment b vs. treatment c. 
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Results 
Study characteristics 
The electronic search identified a total of 2396 titles (for details, refer to Fig. 1). From 
assessing the titles, 2283 were excluded (inter-reader agreement k = 0.98 ±  0.48). The 
resulting number of abstracts obtained was 113, out of which 83 were excluded (inter-
reader agreement k= 0.98 ±  0.25). Thirty full-text articles were obtained, 7 articles were 
further excluded after reading full text. Finally, including studies found through hand 
searching, 9 studies of keratinized tissue and 11 studies of soft tissue volume articles 
met the inclusion criteria. 
Exclusion of studies 
The reasons for excluding studies (7) after full text was obtained were: no reported or 
insufficient clinical details (n=3), an insufficient number of patients (n=1), only hard 
tissue augmentation (n=2) and soft tissue augmentation in combination with implant 
placement and guided bone regeneration (n=1). Details are provided in Table 1. 
Included studies 
The 20 studies that met the inclusion criteria are presented in Table 2 - 5. Table 2 and 4 
represent data for “keratinized tissue augmentation studies” (9 studies) and Table 3 and 
5 refer to clinical studies regarding “soft tissue volume” (11 studies).  
 
Increase in width of keratinized mucosa 
Patient-based treatment outcomes for the width of keratinized tissue retrieved from 9 
studies are presented in Table 2 and 4. Three studies were designed as randomized 
controlled trials (RCT), two as controlled clinical trials (CCT) and the rest of four studies 
were case series reports. 198 patients were treated for gain of keratinized tissue around 
the implants. The methods and techniques used for gain of keratinized tissue included no 
treatment, vestibuloplasty, APF/V (apically positioned flap/vestibuloplasty) in 
combination with autogenous tissues (FGG=free gingival graft), SCTG=subepithelial 
connective tissue graft) and APF/V in combination with allogenic grafts (ADMG) or 
collagen matrices (CM). The mean follow up period was 16.2 months (6-48). The main 
reason for treating the patients encompassed a lack of or an inadequate with of attached 
gingival/keratinized tissue. In summary, three studies were eligible for comparison using 
meta-analyses. The hypothesis of the heterogeneity test could not be rejected (p=0.43), 
therefore a fixed effects model was chosen. 
 
Quality assessment 
The quality assessment of the included studies revealed a high risk of bias for all included 
studies except for the three RCTs (Sanz et al., 2009, Basegmez et al., 2012, Lorenzo et 
al., 2012). 
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Treatment outcomes 
Width of keratinized tissue  
A total of 7 studies (3 RCTs, 2 CCTs, 2 case series) reported on the width of augmented 
keratinized tissue; three studies could be compared for mean gain in keratinized tissue 
using meta-analyses. Four studies investigated the efficacy of collagen matrices 
(Mucograft®, Geistlich, Switzerland and Collatape®, Zimmer Dental, USA) or an acellular 
dermal matrix graft (SureDermTM, Hans Biomed Corp, Korea) compared to autogenous 
grafts (FGG, SCTG) for augmenting the band of keratinized tissue. In two RCTs, the 
application of a CM demonstrated a gain of keratinized tissue as effective and predictable 
as the gold standard, an autogenous SCTG (Sanz et al., 2009, Lorenzo et al., 2012). One 
study evaluated the changes in width of keratinized tissue following APF/V, APF/V plus 
CM and APF/V plus FGG. After 3-4 weeks, the FGG cases showed a greater increase in 
keratinized tissue, while the APF/V plus CM demonstrated a more physiologic and a more 
favorable morphology than the APF/V only cases (Lee et al., 2010). In addition, one 
study reported on the effects of different time-points for performing FGGs (Stimmelmayr 
et al., 2011). In this study no statistical significance (p=0.562) in width of keratinized 
tissue between FGGs performed at the time of implant placement or at the time of 
uncovering the implants (Stimmelmayr et al., 2011). Three studies were eligible for 
meta-analyses (Sanz et al., 2009, Lorenzo et al., 2012, Lee et al., 2010). The I-square 
value of 0% demonstrated homogeneity between the two studies (p=0.4252). The 
overall estimate for mean difference in width of keratinized tissue was -0.32mm (95% CI 
-0.67mm; 0.03mm) in favor of the control groups (control sites using autogenous tissue 
compared to APF/V plus CM). The resulting forest plot diagram is displayed in Figure 2.   
 
Percent shrinkage or contraction of keratinized tissue 
Two RCTs (Sanz et al., 2009, Basegmez et al., 2012) and one case series (Park, 2006) 
reported postoperative shrinkage or contraction of augmented tissue. All studies found 
shrinkage of the augmented grafts (SCTG, CM, ADMG, FGG). Only one study reported on 
% mean graft contraction, revealing more favorable results for the autogenous control 
group (SCTG; 59.7%) compared to a CM group (67.2%) at 30 days (Sanz et al., 2009). 
 
Width of attached mucosa 
One RCT study (Basegmez et al., 2012) reported on the efficacy of two techniques 
(APF/V+FGG or APF/V alone) for increasing the amount of keratinized tissue around the 
implants. Sixty-four patients with 64 implants with a minimal keratinized tissue (<1.5 
mm) and signs of peri-implant mucositis were randomly assigned and treated. The result 
demonstrated that the width of the attached mucosa and the final gains in the FGG group 
were significantly greater than in the APF/V group (Basegmez et al., 2012).   
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Immobilized mucosa 
In order to extend the immobilized mucosa, a case series (Lauer et al., 1996) reported 
on an APF/V procedure in combination with implant placement using transalveolar 
sutures to increase the stability of the lingual peri-implant soft tissue. More immobilized 
mucosa was obtained lingually compared to a control group of six patients with no APF/V 
(Lauer et al., 1996).  
 
Surgery time 
Two RCT studies reported on total surgery time spent to increase the width of keratinized 
tissue (Sanz et al., 2009, Lorenzo et al., 2012). Surgery time spent in both studies was 
less in the CM group compared to the SCTG group. These differences were statistically 
significantly different in both studies. The results of the two studies could be pooled, 
again with a fixed effects model (test for heterogeneity: I-square value=0% p-value 
0.591). The resulting mean difference in surgery time (minutes) was -14.78 (95% CI -
19.4842; -10.0682) in favor of the test groups (CM) compared to the control groups 
(autogenous tissue). The corresponding forest plot is shown in Figure 3. 
 
Patient-reported outcomes 
Two RCT studies assessed the postoperative pain (Sanz et al., 2009, Lorenzo et al., 
2012). In both studies, patient morbidity was evaluated using a visual analogue scale 
(VAS, with a grading of 0-10) through a questionnaire whilst the perception of pain was 
measured based on the utilization of the intake of a postoperative analgesic. Comparable 
results with less morbidity in the CM groups were observed in both studies. At 10 days, 
patients in the SCTG group had higher mean pain scores compared to the CM group. 
These differences were statistically significant. In addition, the amount of anti-
inflammatory medication (ibuprofen) needed by patients during postoperative was 
statistically significantly higher in the SCTG group compared to CM group (Sanz et al., 
2009). 
 
Augmentation of soft tissue volume 
Eleven studies met the inclusion criteria as they report on soft tissue volume (Table 3 
and 5). Two studies were designed as randomized control trials (RCT), three as 
controlled clinical trials (CCT) and the remaining six studies were case series reports. In 
total, 295 patients with 320 sites were treated to enhance the soft tissue volume around 
implants and in partially edentulous areas. The mean follow-up period was 14.5 months 
(range 1-108 months). In four of the studies grafting procedures were performed to 
augment localized alveolar ridge defects (Allen et al., 1985, Studer et al., 2000, Batista 
et al., 2001, Akcali et al., 2013), while in the remaining studies, soft tissue was grafted 
at the day of implant placement (Bianchi and Sanfilippo, 2004, Cornelini et al., 2008, Kan 
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et al., 2009, Wiesner et al., 2010, Simion et al., 2012) and/or during the healing period 
of the implant (Speroni et al., 2010, Schneider et al., 2011, Simion et al., 2012). The 
methods and surgical techniques used for increasing soft tissue volume included: 
immediate implant placement with SCTG, hydroxylapatite graft, a collagen matrix in 
combination with a growth factor (platelet-derived growth factor-BB=PDGF-BB), allogenic 
dermal matrix graft (ADMG), a SCTG (alone) and a palatal vascularized interpositional 
periosteal-connective tissue graft (VIPCG). No meta-analysis could be performed due to 
heterogeneity in the study design and treatment modalities.  
 
Quality assessment 
The quality assessment of the included studies revealed a high risk of bias for all included 
studies except for one RCT (Wiesner et al., 2010). 
 
Treatment outcomes 
Volume increase measured by two-dimensional methods 
Four studies reported horizontal and/or vertical changes in soft tissue volume following 
soft tissue grafting procedures using stents and periodontal probes or endodontic 
instruments to measure the changes over time. In a case series, localized alveolar 
defects in eight patients with 18 sites were treated with ADMG. A gain in vertical ridge 
width of 0.61mm (SD 0.77) and in horizontal ridge width of 1.72mm (SD 0.59) was 
reported during the course of 6 months (Batista et al., 2001). A newly developed 
collagen matrix was evaluated in a prospective case series, using the matrix in 
combination with a growth factor (PDGF-BB) at the day of implant placement or at 
second stage surgery (Simion et al., 2012). The obtained gains in ridge width ranged 
between 0.35mm and 2.14mm with standard deviations of up to 3.27mm at 4 months 
depending on the level where the measurements were taken using a stent and an 
endodontic instrument. Since no other treatment modalities were tested, neither the 
effect of the collagen matrix alone nor the effect of the growth factor can be estimated 
(Simion et al., 2012). Three years after grafting with SCTGs at the day of implant 
uncovering, 14 sites in 14 patients demonstrated a mean gain of 1.4mm in mucosal 
thickness in a subsequent case series (Speroni et al., 2010). The only RCT reporting on 
soft tissue volume increase following grafting at implant placement, tested the effect of 
SCTGs vs. no treatment in 10 patients in a split-mouth design (Wiesner et al., 2010). 
Statistically significant more favorable outcomes were obtained using SCTGs (mean 
thickness of 3.2mm±0.42mm) compared to sites not receiving soft tissue grafting 
(1.9mm±0.32mm). 
 
Volume increase measured by three-dimensional methods 
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Only three studies reported truly three-dimensional changes of the soft tissue volume 
following grafting. In the first one, the Moiré method was used to calculate the volume 
changes following grafting with two types of autogenous tissue grafts in localized alveolar 
defects (Studer et al., 2000). The study demonstrated a volume gain between 159 mm3 
(SCTG; SD = 80) and 104 mm3 (FGG; SD = 31). The differences between the two 
treatment modalities were statistically significant in favor of the SCTG group, while 
untreated defects showed a slight increase in volume of 6mm3 (SD = 5.4), which was 
statistically significantly different compared to the two test groups using autogenous 
tissue (Studer et al., 2000). In a more recent RCT, SCTGs were compared to VIPCGs 
(interpositional connective tissue grafts) for augmentation of localized alveolar defects 
(Akcali et al., 2013). A more advanced technique was used to calculate the volume 
changes and revealed statistically significant more volume for VIPCG-treated sites 
(1.18mm; range 0.16mm to 1.75mm) compared to free SCTGs (0.63mm; 0.28mm-
1.22mm). In a case series, SCTGs were used during the healing phase of implants in 16 
sites and patients (Schneider et al., 2011). The mean increase due to grafting was 
0.55mm with a standard deviation of 0.53mm after 4 weeks of healing (Schneider et al., 
2011).  
 
Shrinkage 
In a case series, 21 patients with 26 localized alveolar defects were treated either with a 
SCTG or hydroxylapatite implants. All sites with SCTG demonstrated some shrinkage 
within the first 4-6 weeks, but the augmented sites remained stable for three years.  In 
all but 2 sites (out of 12) treated with hydroxylapatite implants, no shrinkage was 
observed (Allen et al., 1985). The shrinkage of the horizontal ridge width amounted to 
41.4% over 6 months when localized alveolar defects were augmented with ADMGs in a 
case series (Batista et al., 2001). This is in line with results from a RCT comparing SCTGs 
(shrinkage 47% after 6 months) with similar defects to VIPCG= Interpositional 
connective tissue grafts (shrinkage of 6.4% only) (Akcali et al., 2013). 
 
Esthetic outcomes 
The Jemt score (Jemt, 1997) was used to evaluate the esthetic outcomes in two studies 
(Cornelini et al., 2008, Kan et al., 2009). Both studies demonstrated favorable results for 
soft tissue grafting with higher papilla scores during the course of the study (2.15 years; 
(Kan et al., 2009) and significantly better outcomes (higher papilla scores) compared to 
sites without grafting for immediate implants combined with SCTGs (Cornelini et al., 
2008). The same two studies also evaluated the position of the mucosal margin 
compared to neighboring teeth. Similar to the Jemt scores, a more favorable outcome 
with a higher mean facial line was observed after 2.15 years (Kan et al., 2009), while 
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grafted sites revealed significantly higher mucosal margin levels for grafted sites after 12 
months (Cornelini et al., 2008). 
 
Additional outcome parameters 
Additional outcome measures included the amount of keratinized mucosa, the stability of 
the emergence profile, the patient satisfaction (all in (Bianchi and Sanfilippo, 2004) and 
the tissue biotype changes (Kan et al., 2009). 
 
 
 16 
Discussion 
The present systematic review focused on the question whether there is superiority of 
one method over others for soft tissue grafting around implants and in partially 
edentulous spaces. For keratinized tissue, nine studies were included and three of them 
could be compared using meta-analyses. For the augmentation of soft tissue volume, a 
final number of 11 studies met the inclusion criteria. Due to heterogeneity between the 
studies, no meta-analysis could be performed. 
 
Increase in width of keratinized tissue 
Gain of keratinized tissue 
Seven studies specifically reported on various techniques and materials to augment 
keratinized tissue around dental implants. In all studies, the width of keratinized tissue 
could be successfully augmented. Due to a large heterogeneity between the studies, with 
some studies missing control groups and different time-points applying the soft tissue 
grafting (simultaneous with implant placement, during the healing phase of the implants 
and after the insertion of the final reconstruction), it is difficult to recommend a specific 
technique. The selection of the included studies also demonstrates advances and trends 
in clinical research. In older studies, either an APF/V alone or in combination with 
autogenous tissue harvested from the patient’s palate was the treatment of choice (Lauer 
et al., 1996, ten Bruggenkate et al., 1991). The main disadvantage of using autogenous 
tissue results from the morbidity associated with the harvesting procedure and the 
subsequent healing. Research has therefore focused on alternative materials and 
techniques. In one of the studies, a human-derived ADMG was applied (Park, 2006). This 
material has been documented extensively in dentistry in various fields, such as for gain 
of keratinized tissue around teeth, for recession coverage, for gain of keratinized mucosa 
around dental implants and for volume increase (Wei et al., 2000, Aichelmann-Reidy et 
al., 2001, Batista et al., 2001, Carney et al., 2012). The advantage of using alternative 
materials is documented with less patient morbidity compared to autogenous tissue for 
gain of keratinized gingiva (Griffin et al., 2006). Around dental implants, the combination 
of an APF/V and ADMG was successful to augment keratinized tissue (Park, 2006). 
However, due to the lack of a control group, any comparison to the gold standard 
(autogenous tissue) is missing. No further included studies were using this material. In 
contrast, a number of human studies used ADMG for gain of keratinized tissue. High 
shrinkage rates were reported during healing around teeth (Wei et al., 2000) and the 
tissue, histologically resembled scar tissue (Wei et al., 2002). More recently, collagen 
matrices were developed and extensively evaluated in preclinical and clinical studies 
(Rocchietta et al., 2012, Jung et al., 2011, Thoma et al., 2012a, Vignoletti et al., 2011, 
Jung et al., 2013, Jepsen et al., 2013). Three of the included studies reported on the use 
of two types of collagen matrices (Sanz et al., 2009, Lee et al., 2010, Lorenzo et al., 
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2012). In all three studies, autogenous tissue served as a control group. The increase in 
width of keratinized tissue with a range of 1.8mm to 2.3mm indicates a successful use of 
both CM types. Still, the meta-analysis revealed inferiority of the collagen matrices in all 
three studies compared to control groups with autogenous tissue. Clinically, the WMD of 
-0.32mm only may be negligible. This may even more serve as part of the discussion, 
since alternative devices (e.g. CM) can significantly reduce patient morbidity, reduce the 
overall treatment time and slightly improve esthetics compared to control groups (Griffin 
et al., 2006, Sanz et al., 2009, Lorenzo et al., 2012, Thoma et al., 2012a). In one study, 
the width of keratinized mucosa was reported as gain in width of attached mucosa 
(Basegmez et al., 2012). While at teeth, the keratinized tissue (i.e. the gingiva) consist 
of two parts, the attached gingiva and the free gingiva, at implant sites, no such terms 
exist. The dimension of the keratinized tissue appears to be similar at teeth and implant 
sites, but a clear soft tissue attachment to implants has yet to be reported (Berglundh 
and Lindhe, 1996). It may therefore be speculated that the reported attached mucosa 
represents the keratinized mucosa found in other studies.   
 
Percent shrinkage and contraction of keratinized tissue 
The changes in width over time following the initial augmentation procedure is of great 
importance and serves as a reliable mean to estimate the predictability of the applied 
technique. Therefore, the overall contraction or shrinkage over time needs to be 
evaluated. Three studies reported on these outcomes and revealed that independently of 
the applied surgical technique or material used to augment, a certain loss of the initially 
augmented width has to be accepted. This ranged quite extensively in the present 
systematic review, with one study reporting only 2% of shrinkage over 12 months 
(Basegmez et al., 2012), while the remaining two studies reported shrinkage rates higher 
than 50% at one or six months (Park, 2006, Sanz et al., 2009). The variability may be 
due to the use of different techniques (vestibuloplasty according to Edlan & Mejchar, 
APF/V), different observation time-points (1, 6 and 12 months), differences in graft 
materials (CM, FGG, SCTG) and different indications (inadequate width of keratinized 
mucosa, inadequate width of attached mucosa, peri-implant mucositis). Other influences 
such as the thickness of the graft, which appears to be important when augmenting 
keratinized tissue around teeth (Mormann et al., 1981) and the lack of a 
prevascularization (for CM compared to autogenous tissue) could not be evaluated due to 
a low number of include studies reporting these outcomes. 
 
Surgery time 
As reported above, the gain in width of keratinized mucosa is not the only outcome 
parameter that may favor one over the other technique. In two RCTs, the overall 
treatment time was calculated and clearly demonstrated that by avoiding the use of 
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autogenous tissue and the associated harvesting procedure, the surgery time can be 
significantly reduced (Sanz et al., 2009, Lorenzo et al., 2012). The meta-analysis 
revealed a mean difference of roughly 15 minutes in favor of the CM groups. This has to 
be considered as a major advantage for the use of alternative devices and may be 
directly correlated with the postoperative healing and the patient morbidity.  
 
Patient-reported outcomes 
The postoperative complications of soft tissue grafting procedure include bleeding, 
swelling as major contributors (Wessel and Tatakis, 2008, Dordick et al., 1976b, Dordick 
et al., 1976a, Griffin et al., 2006, Farnoush, 1978, Del Pizzo et al., 2002). Several studies 
evaluated the patient morbidity following gingival augmentation. The data are not 
conclusive, but predominantly demonstrate less morbidity associated with soft tissue 
substitutes compared to autogenous tissue (McGuire et al., 2008, Griffin et al., 2006, 
McGuire and Nunn, 2005). Only two included studies provided data of postoperative pain 
in the present review. The information derived from the two RCTs clearly demonstrates 
superiority with less morbidity for soft tissue substitutes compared to autogenous tissue 
(Sanz et al., 2009, Lorenzo et al., 2012). Data were provided by questionnaires and the 
intake of pain killer medication in the follow-up. Since both studies were not designed as 
split-mouth studies, the data are conclusive and more relevant than data obtained in 
previous studies. In older studies, split-mouth designs appeared to confuse patients, 
making it difficult to differentiate between two sites (McGuire and Nunn, 2005, McGuire 
et al., 2008). Therefore, in a previous systematic review on soft tissue grafting 
procedures, no benefit was shown for soft tissue substitutes (Thoma et al., 2009). The 
outcomes on patient morbidity are of major relevance and might help to thrive the choice 
for a grafting material towards soft tissue substitutes in the future. 
 
Augmentation of soft tissue volume 
Compared to a previous systematic review (Thoma et al., 2009), the number of included 
studies increased with 11 studies finally meeting the inclusion criteria. The difference is 
due to broader inclusion criteria (implant sites, partially edentulous sites), a number of 
very recent studies applying new materials and techniques (growth factors, soft tissue 
substitutes) and the development of new techniques to assess soft tissue volume 
changes (non-invasive three-dimensional analyses). Still, due to heterogeneity between 
the studies, no meta-analysis could be performed. 
 
Volume increase measured by two-dimensional methods 
Four studies reported two-dimensional changes of soft tissue volume applying 
autogenous tissue (SCTG) and soft tissue substitutes (CM, ADMG) (Batista et al., 2001, 
Simion et al., 2012, Speroni et al., 2010, Wiesner et al., 2010). The measurements were 
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performed using endodontic instruments or periodontal probes, mostly with the aid of a 
standardized stent. The outcomes provided variability with respect to the increase in soft 
tissue thickness over time with a range of 0.35mm to 3.2mm depending on the location 
(buccal at different levels, occlusal) and the follow-up time-point (4 months to 3 years). 
In all studies, a volume increase was obtained independent of the technique and 
material, but it was also demonstrated that some shrinkage might occur over time. 
Similar to studies for gain of keratinized tissue, autogenous tissue appears to be the gold 
standard as it was used most often, but new soft tissue substitutes are being evaluated. 
Research has strongly focused on the development and testing of alternative devices with 
collagen matrices being the most promising ones (Thoma et al., 2013). Unlike for gain of 
keratinized tissue where preclinical and clinical data are published (Jung et al., 2011, 
Sanz et al., 2009, Lorenzo et al., 2012), collagen matrices for gain of soft tissue volume 
are scare and mostly documented in vitro and in preclinical studies (Mathes et al., 2010, 
Thoma et al., 2010, Thoma et al., 2011, Thoma et al., 2012b). Only one clinical study 
used a collagen matrix (Simion et al., 2012), which was originally designed to serve as a 
matrix for gain of keratinized tissue and showed only a minimal increase in thickness 
based on preclinical data (Jung et al., 2011). Therefore, this matrix was combined with a 
growth factor to enhance the vascularization and the connective tissue formation (Simion 
et al., 2012). The outcomes of the study demonstrated a short-term increase in soft 
tissue volume at all levels. Some more data at just one buccal level over 3.5 years, 
however, revealed that the obtained soft tissue thickness decreased by more than 50% 
to roughly 0.9mm (Simion et al., 2012). This demonstrates that a soft tissue substitute 
for soft tissue volume increase may have additional requirements for long-term stability 
and a successful outcome. In order to overcome these issues and to meet the demands 
and requirements for soft tissue substitutes, a new modified collagen matrix with cross-
linking has been tested over the course of the past years. In vitro and preclinical data are 
favorable and a direct comparison with the gold standard, the autogenous graft, 
demonstrated non-inferiority in a canine model (Mathes et al., 2010, Thoma et al., 2010, 
Thoma et al., 2011, Thoma et al., 2012b). Clinical data however are still lacking. 
 
Volume increase measured by three-dimensional methods 
Recent development not only focused on new devices but also on the evaluation of non-
invasive methods to assess volumetric changes (Windisch et al., 2007, Fickl et al., 2009, 
Strebel et al., 2009). Three studies used casts to evaluate the soft tissue volume over 
time. In all three studies, autogenous tissue was used for volume increase, in two studies 
for partially edentulous sites (Studer et al., 2000, Akcali et al., 2013), in one for volume 
increase at implant sites (Schneider et al., 2011). Again, due to heterogeneity, the 
outcomes could not be compared, but data provide clinically more relevant data since the 
measurements capture the entire augmented area. The mean augmented thickness 
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ranged between 0.55mm and 1.18mm, while the remaining study provided an increase 
of 104mm3 to 159mm3 (Studer et al., 2000). The outcomes at partially edentulous sites 
are difficult to put into context unless esthetic, functional and/or long-term data are 
provided. At implant sites, a soft tissue thickness of 2mm appears to be the threshold 
thickness at the buccal aspect for more esthetic outcomes (Jung et al., 2007, Jung et al., 
2008, van Brakel et al., 2011). Unfortunately, the entire soft tissue thickness and 
suitable esthetic outcome parameters were not provided by the included study 
(Schneider et al., 2011). Conclusions on whether or not the treatment was successful are 
difficult to draw. 
 
Shrinkage 
Similar to keratinized tissue, the overall shrinkage rate provides data on the reliability of 
the applied technique and material. Autogenous tissue was reported to shrink by more 
than 40% in two studies, while a pedicle flap (VIPCG) appears to be more reliable 
resulting in less shrinkage over time (6.4% at 6 months) (Akcali et al., 2013). Data on 
soft tissue substitutes were not reported in the included studies.  
 
Esthetic outcomes 
There is a huge variety of esthetic factors reported in the literature (Benic et al., 2012). 
For maximal esthetics, the soft tissue thickness at the buccal aspect of the implant sites 
and the height of the papillae appears to be the key factors (Thoma et al., 2013). The 
Jemt score (Jemt, 1997) is considered an easily applicable method to assess the esthetic 
outcome in the papilla area and provides relevant clinical information on the esthetic 
outcome at implant sites. Two included studies demonstrated that the use of autogenous 
tissue combined with immediate placement results in favorable clinical esthetics at one 
and 2.15 years (Kan et al., 2009, Cornelini et al., 2008). Since one of the studies was 
designed as a CCT, data on non-grafted sites are included. The outcomes clearly 
demonstrate that necessity and the superiority of grafted sites resulting in better 
esthetics over the course of one year (Cornelini et al., 2008).
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Conclusion 
The present systematic review revealed that for gain of keratinized mucosa at implant 
sites, various methods and various materials could be used successfully. All applied 
techniques were based on an APF/V in combination with autogenous tissue (SCTG/FGG) 
or a soft tissue substitute (ADMG/CM) and rendered a gain in keratinized tissue for an 
observation period of up to 48 months. In contrast to gingival augmentation, only one 
study reported on APF/V alone, which might indicate that most studies were 
commercially funded. However, some shrinkage may occur with all applied grafting 
materials and may result in a decrease in width of keratinized tissue of more than 50% 
within a couple of months. For soft tissue volume augmentation, autogenous tissue 
(SCTG) has to be considered as treatment of choice resulting in an increase in soft tissue 
thickness at implant sites and in partially edentulous sites. Soft tissue substitute lack 
clinical data and can currently not be recommended. Again, some shrinkage of the 
augmented sites has to be considered. From an esthetic point of view, soft tissue volume 
grafting concomitant with immediate implant placement may result in superior outcomes 
with respect to papilla height and the level of the marginal mucosa compared to natural 
teeth and control groups. 
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Future direction of research 
The present systematic identified a relatively low number of studies to be included for 
gain of keratinized tissue around dental implants and for gain of soft tissue volume 
around dental implants and in partially edentulous sites. Moreover, there was a lack of 
randomized controlled clinical trials (RCTs), specifically for gain of soft tissue volume. For 
gain of keratinized tissue, some RCTs were available, but appeared to be fully sponsored 
by companies, thereby including a greater risk of bias. In order to provide the clinicians 
with data on optimal techniques and materials, more self-funded studies or studies 
funded by independent organizations and foundations are needed. Such RCTs would have 
a great impact for the benefit of patients and clinicians.  
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Figure legends 
 
Figure 1: Search strategy 
 
Figure 2:  
Meta-analyses for gain in width of keratinized tissue. Mean difference (mm) for test 
minus control. APF = apically positioned flap; SCTG = subepithelial connective tissue 
graft; FGG = free gingival graft; CM=Collagen matrix; I squared (percentage variation 
attributable to heterogeneity) = 0%, P =0.4254; CI = confidence interval) 
 
Figure 3:  
Meta-analyses for surgery time. Mean difference shorter surgery time (min) for test 
minus control. APF = apically positioned flap; SCTG = subepithelial connective tissue 
graft; CM=Collagen matrix; I squared (percentage variation attributable to 
heterogeneity) = 0%, P =0.591; CI = confidence interval) 
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Table 1. Excluded studies with reason for exclusion 
 
 
author reason for exclusion 
(Alpert, 1994) only descriptive, no data 
(Becker, 2001) hard tissue only 
(Bidra and Rungruanganunt, 2011) 2 cases only 
(Collins and Nunn, 1994) hard tissue augmentation only 
(Fagan et al., 2008) no data, immediate implant placement and soft tissue augmentation at the same time 
(Kwakman et al., 1998) no detailed information about procedures 
(Liu and Weisgold, 2002) no data, only classifications 
 
 
 
 
  
 2 
Table 2.              Included studies: augmentation of keratinized mucosa 
Author Year of publication 
Study 
design 
 
Indication for treatment 
 
Test treatment Control 1 treatment 
control 2 
treatment 
Follow-
up 
period 
(months) 
(ten Bruggenkate 
et al., 1991) 
1991 Case 
series 
Inadequate width of keratinized mucosa <2 mm APF/V plus FGG NA NA 6-32 
(Lauer et al., 
1996) 
1996 Case 
series 
Inadequate width of attached gingiva APF/V in 
combination with 
implant placement 
No treatment NA 18 
 
(Park, 2006) 2006 Case 
series 
Inadequate width of attached gingival ≤ 2 mm APF/V  plus ADMG NA NA 6 
 
(Sanz et al., 2009) 2009 RCT Inadequate width of keratinized mucosa <2 mm APF/V  plus CM 
(Mucograft) 
APF/V  plus SCTG NA 6 
 
(Lee et al., 2010) 2010 CCT If keratinized mucosa > 3 mm ;  APF/V 
                                2-3 mm ;  APF/V  plus CM  
                                minimal ;  APF/V  plus FGG 
APF/V  plus CM 
(Collatape) 
APF/V APF/V  plus FGG 6 
 
(Lorenzo et al., 
2012) 
2012 RCT Inadequate width of keratinized mucosa <1 mm APF/V  plus CM 
(Mucograft) 
APF/V  plus CTG NA 6 
 
(Stimmelmayr et 
al., 2011) 
2011 CCT Inadequate width of keratinized tissue, from buccal to 
lingual had to be 3.5 mm or more 
Single stage 
implant placement 
and ridge 
augmentation with 
later FGG 
Two stage ridge 
augmentation and 
later implant 
placement and FGG 
NA 12 
 
(Basegmez et al., 
2012) 
2012 RCT Inadequate width of attached mucosa <1.5 mm, 
perimplant mucositis 
APF/V  plus FGG vestibuloplasty 
according to Edlan 
& Mejchar) 
NA 12 
 
(Bruschi et al., 
2012) 
2012 Case 
series 
Inadequate width of attached gingiva APF/V in 
combination with 
implant placement 
NA NA 48  
 
 
 
 3 
(CCT = controlled clinical trial; RCT = randomized controlled clinical trial; APF/V = apically positioned flap/vestibuloplasty procedure; SCTG = subepithelial 
connective tissue graft;  
FGG = free gingival graft; ADMG = acellular dermal matrix graft; CM=collagen matrix) 
 
  
 4 
 
Table 3.  Included studies: augmentation of soft tissue volume 
Author Year of publication 
Study 
design Indication for treatment Test treatment 
Control 1 
treatment 
control 2 
treatment 
Follow-
up 
period 
(months) 
(Allen et al., 1985) 1985 Case 
series 
Localized alveolar ridge defect SCTG Hydroxylapatite NA 36 for 
SCTG and 
18 for HA 
(Studer et al., 
2000) 
2000 RCT Localized alveolar ridge defect SCTG FGG No treatment 3.5 
(Batista et al., 
2001) 
2001 Case 
series 
Localized alveolar ridge defect ADMG NA NA 6 
(Bianchi and 
Sanfilippo, 2004) 
2004 CCT Immediate implant placement Immediate implant 
+SCTG 
Immediate implant NA 12-108 
(Cornelini et al., 
2008) 
2008 CCT Extraction socket and immediate implant placement Immediate implant 
+SCTG 
Immediate implant NA 12 
(Kan et al., 2009) 2009 Case 
series 
Immediate implant placement Immediate implant 
+SCTG 
NA NA 25.8 
(Wiesner et al., 
2010) 
2010 RCT At implant placement SCTG at implant 
placement 
No SCTG NA 12 
(Speroni et al., 
2010) 
2010 retrospect
ive case 
series 
At second stage surgery SCTG at 2nd stage 
surgery 
NA NA 36 
(Schneider et al., 
2011) 
2011 Case 
series 
During healing period of implant placement SCTG at healing 
period of implant 
NA NA 4 
 5 
 
  
(Simion et al., 
2012) 
2012 Case 
series 
Localized ridge augmentation at implant placement or after 
implant placement 
CM+PDGF-BB NA NA 4 
(Akcali et al., 
2013) 
2013 RCT Localized alveolar defect Interpositional 
connective tissue 
graft (VIPCG) 
SCTG NA 6 
 CCT = controlled clinical trial; RCT = randomized controlled clinical trial; SCTG = subepithelial connective tissue graft;  
FGG = free gingival graft; ADMG = acellular dermal matrix graft; CM=Collagen matrix; PDGF = platelet derived growth factor; 
VIPCG= Interpositional connective tissue graft. 
 6 
Table 4. Characteristics of included studies: width of keratinized mucosa 
 
author 
year of 
publication 
study 
design 
total 
number 
of 
patients 
total 
number 
of      
sites 
number   
of 
patients 
test 
number   
of         
sites 
test 
number 
of 
patients 
control 1 
number 
of      
sites 
contol 1 
number 
of 
patients 
control 2 
number 
of      
sites 
control2 
follow-
up 
period 
(months) test treatment 
control 1 
treatment 
control 2 
treatment 
(ten 
Bruggenkate 
et al., 1991) 
1991 Case 
series 
30   30  30   6-32 APF/V plus FGG   
(Lauer et al., 
1996) 
1996 Case 
series 
12 12 6 6 6 6   18 APF/V in 
combination with 
implant 
placement 
No treatment  
(Park, 2006) 2006 Case 
series 
10 10 10 10     6 APF/V plus 
ADMG 
  
(Sanz et al., 
2009) 
2009 RCT 20 20 10 10 10 10   6 APF/V plus CM 
(Mucograft) 
APF/V plus SCTG  
(Lee et al., 
2010) 
2010 CCT 9 14 3 3 3 3 3 8 6 APF/V plus CM 
(Collatape) 
APF/V APF/V plus 
FGG 
(Lorenzo et 
al., 2012) 
2012 RCT 24 24 12 12 12 12   6 APF/V plus CM 
(Mucograft) 
APF/V plus CTG  
(Stimmelmayr 
et al., 2011) 
2011 CCT 29 70 19 46 10 24   12 Single stage 
implant 
placement and 
ridge 
augmentation 
with later FGG 
Two stage ridge 
augmentation 
and later implant 
placement and 
FGG 
 
 7 
(Basegmez et 
al., 2012) 
2012 RCT 64 64 32 32 32 32   12 APF/V plus FGG vestibuloplasty 
according to 
Edlan & Mejchar) 
 
(Bruschi et 
al., 2012) 
2012 CCT 85 131 85 131     48 APF/V in 
combination with 
implant 
placement 
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Table 4 (continue) 
author outcome measure 
baseline 
test SD 
post-
surgery 
test SD 
change 
test 
change 
test 
SD 
baseline 
control 
1 SD 
post-
surgery 
control 1 SD 
change 
control 
1 
change 
control 
SD 
(ten 
Bruggenkate 
et al., 1991) 
Width of keratinized tissue 
(mm) NR NR 5 (3-8) NR NR NR NR NR NR NR NR NR 
(Lauer et al., 
1996) 
Immobile mucosa (mm) 
Attached gingiva (mm) NR NR 
L4.2,B2.2 
L2.9,B0.7 NR NR NR NR NR 
L2.5,B2.6 
L0.8.B0.8 NR NR NR 
(Park, 2006) 
Width of keratinized tissue 
(mm) 1.62 0.09 6.24 0.19 NR NR 1.59 0.07 1.66 0.1 NR NR 
(Sanz et al., 
2009) 
Width of keratinized tissue 
(mm) 2.13 1.2 6.3 1.67 NR NR 1.76 1.27 5.08 1.49 NR NR 
(Lee et al., 
2010) 
Width of keratinized tissue 
(mm) 1.3 0.5 3.1 1 1.8 0.75 3 0 4.6 0.5 1.6 0.25 
(Lorenzo et 
al., 2012) 
Width of keratinized tissue 
(mm) 0.5 0.52 2.8 0.42 NR NR 0.42 0.51 2.75 1.55 NR NR 
(Stimmelmayr 
et al., 2011) keratinized tissue (mm) 3 NR B3.7,L2.6 NR 
B+3.3,L-
0,05 NR 2.75 NR B3.3,L2.65 NR NR NR 
(Basegmez et 
al., 2012) 
Width of attached mucosa 
(mm) 0.75 0.36 3.11 0.58 2.36 0.49 0.67 0.32 1.83 0.72 1.15 0.81 
 9 
(Bruschi et 
al., 2012) keratinized tissue (mm) 2.3 0.25 7.37 2.12 NR NR NR NR NR NR NR NR 
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Table 4 (continue) 
author 
baseline 
control 
2 SD 
post-
surgery 
control 
2 SD 
change 
control 
2 SD 
effect of 
test vs. 
control 1 
effect of 
test vs. 
control 2 
effect of 
control 1 
vs. 
control 2 
(ten 
Bruggenkate 
et al., 1991) NR NR NR NR NR NR NR NR NR 
(Lauer et al., 
1996) NR NR NR NR NR NR significant NR NR 
(Park, 2006) NR NR NR NR NR NR NR NR NR 
(Sanz et al., 
2009) NR NR NR NR NR NR 
Not 
significant NR NR 
(Lee et al., 
2010) 0.5 0 3 1.6 2.5 0.55 NR NR NR 
(Lorenzo et 
al., 2012) NR NR NR NR NR NR 
Not 
significant NR NR 
(Stimmelmayr 
et al., 2011) NR NR NR NR NR NR 
Not 
significant NR NR 
 11 
(Basegmez et 
al., 2012) NR NR NR NR NR NR significant NR NR 
(Bruschi et 
al., 2012) NR NR NR NR NR NR NR NR NR 
Table 5: Table 5: Characteristics of included studies: augmentation of soft tissue volume 
 
author 
year of 
publication study design 
total number 
of patients 
total number 
of sites 
number of 
patients test 
number of 
sites test 
number of 
patients 
control 1 
number of 
sites control 
1 
number of 
patients 
control 2 
(Allen et al., 
1985) 
1984 Case series 21 26 NA 14 NA 12 NA 
(Studer et 
al., 2000) 
2000 RCT 30 30 12 12 12 12 6 
(Batista et 
al., 2001) 
2001 Case series 8 18 8 18 NA NA NA 
(Bianchi and 
Sanfilippo, 
2004) 
2004 CCT 116 116 96 96 20 20 NA 
(Cornelini et 
al., 2008) 
2008 CCT 34 34 17 17 17 17 NA 
(Kan et al., 
2009) 
2009 Case series 20 20 20 20 NA NA NA 
(Wiesner et 
al., 2010) 
2010 RCT 10 20 10 10 10 10 NA 
(Speroni et 
al., 2010) 
2010 
retrospective 
case series 14 14 14 14 NA NA NA 
(Schneider 
et al., 2011) 
2011 Case series 16 16 15 15 NA NA NA 
(Simion et 
al., 2012) 
2012 Case series 6 6 6 6 NA NA NA 
(Akcali et 
al., 2013) 
2013 RCT 20 20 10 10 NA NA NA 
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Table 5 continue 
 
number of 
sites 
control 2 
follow-up 
period 
(month) test treatment control 1 treatment 
control 2 
treatment 
outcome 
measure outcome test SD 
NA 1.5 SCTG Hydroxylapatite NA 
shrinkage 
(descriptive) 
14 of 14 sites: 
shrinkage within first 
4-6 weeks, then stable 
for 3 years NR 
6 3.5 SCTG FGG untreated defect 
soft tissue 
volume 159 mm3 80 mm3 
NA 6 ADMG NA NA 
gain in 
horizontal 
ridge width 
(mm) 1.72 0.59 
NA 48 
immediate implants 
+ SCTG immediate implants             NA 
keratinized 
mucosa NR NR 
NA 12 
immediate implants 
+ SCTG immediate implants             NA 
papilla Index 
(Jemt) 
19 papillae (score 2); 
15 papillae (score 3) NR 
NA 26 
immediate implants 
+ SCTG NA       NA biotype 
thick biotype at latest 
follow-up in all sites NR 
NA 12 SCTG no SCTG                             NA 
pink esthetic 
score 11.32 1.63 
NA 36 SCTG NA     NA 
mucosal 
thickness 
(stent) 1.4mm NR 
NA 4 SCTG NA     NA 
3D volume 
measurements 
based on casts 0.55mm 0.53mm 
NA 4 
collagen matrix + 
rhPDGF-BB NA     NA 
2D volume 
measurements 
using stents 
0.87mm (apical); 
2.14mm (central); 
0.35mm (occlusal) 
2.13mm (apical); 
3.27mm (central); 
3.20mm (occlusal) 
NA 6 VIPCG SCTG 
 
3D volume 
measurements 
based on casts 1.18mm 0.16mm-1.75mm 
 14 
 
Table 5 continue 
 
outcome 
control 1 SD control 1 
outcome control 
2 SD control 2 
effect of test 
vs. control 1 
effect of test 
vs. control 2 
effect of control 
1 vs. control 2 
10 of 12 sites: 
no shrinkage 
      104mm3 31mm3 6mm3 5.4mm3 significant significant significant 
       
NR NR NA NA 
higher values 
for test group NA NA 
22 papillae 
(score 2); 12 
papillae (score 
3) NA NA NA 
in favor of test 
group NA NA 
       
8.45 1.46 NA NA 
statistically 
significant in 
favor of test 
group NA NA 
       
0.63mm 
0.28mm-
1.22mm NA NA 
statistically 
significant in 
favor of test 
group NA NA 
 
 
 
 (CCT = controlled clinical trial; RCT = randomized controlled clinical trial; SCTG = subepithelial connective tissue graft;  
FGG = free gingival graft; ADMG = acellular dermal matrix graft; VIPCG=palatal vascularized interpositional periosteal-connective tissue 
graft; SD=standard deviation 
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final number of studies 
included 
keratinized tissue: 9 
final number of studies 
included 
soft tissue volume: 11 
further hand searching 2 articles 
on soft tissue volume 
(references of full text articles) 
 
further hand searching 6 articles 
on keratinized tissue 
(references of full text articles) 
 
first electronic search: 
2396 titles 
 independently selected by 2 reviewers  
  and agreed by both: 113 titles  
 abstracts obtained 
 independently selected by 2 reviewers  
  and agreed by both: 30 abstracts 
 full text obtained 
keratinized tissue: 3 
inter-reader agreement 
k = 0.98 ±  0.48 
review: 11 
 
excluded: 7 
 
inter-reader agreement 
k = 0.98 ±  0.25 
soft tissue volume: 9 
final number of reviews 
included for hand search: 
13 
further hand searching 2 articles 
(references of full text articles) 
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